Skip to main content
Caplight Logo









Preve

Preve

Private
BrisbaneHealthcare & Life Scienceshttps://preve.co/

Last Round

Seed

May 23, 2025

Total Funding Raised

$1.71M

Company Overview

Preve is an AI-powered clinical assistant and patient engagement platform that provides automated clinical documentation, treatment planning, and rehabilitation programs for physiotherapists.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Medical AI, Patient Engagement, NLP & Conversational AI, Document Management

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinical documentationAI scribephysiotherapy softwaremedical AIpatient engagementAI clinical assistantelectronic medical recordEMRpractice management systemPMStreatment planningvertical SaaSAI copilotautomated chartingallied health software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Preve Comparables

Compare Preve with similar companies based on industry and business-model similarity.

Preve comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Claire Health LLC
88%
AllyScribe
85%
CliniScribe
84%

Preve Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 23, 2025
Pre SeedJul 1, 2024

Preve Investors

Notable investors and investment history

Preve investors
InvestorRounds
StartmateSeed, Pre Seed
Carthona CapitalSeed
Black Sheep CapitalSeed
ArchangelSeed, Pre Seed
Exhort VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Monthly visitors grew 40% MoM, reaching 32.8K.

  • Jul 14, 2025

    Grew 20% QoQ from 15 to 18 employees.

Preve Filings

Explore SEC and related filing metadata, where available.

Preve filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Preve's valuation, stock price, and market status.

Is Preve a public or private company?

Preve is a private company.

What is the current stock price of Preve?

Preve is a private company with no public stock price. No recent secondary market data is available.

How much is Preve worth (valuation)?

Valuation information for Preve is not publicly available.

Can I buy Preve stock?

Preve shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Preve's last funding round?

Preve's most recent funding round was Seed on May 23, 2025.

Who are the main investors in Preve?

Key investors in Preve include Carthona Capital.

Will Preve IPO soon?

No public IPO plans have been announced for Preve.

How can I track Preve secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Preve's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBrisbane
Employee Range6
Year Founded2023
Last FundingMay 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?